Value of routine bone marrow examination in pediatric acute myeloid leukemia (AML): A study of the Dutch Childhood Oncology Group (DCOG)

Pediatric Blood and Cancer

Volumn 59, Issue 7, 2012, Pages 1239-1244

  Hageman, Ilse M G ^a   Peek, Annemarie M L ^a,b   de Haas, Valérie ^a,c   Damen Korbijn, Carin M ^c   Kaspers, Gertjan J L ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Dutch Childhood Oncology Group DCOG   (Netherlands)

Author keywords

Acute myeloid leukemia; Bone marrow examination aspiration(s); Bone marrow relapse; Childhood; Routine screening

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; CHILD; CHILDHOOD CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

BONE MARROW; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 84867347653     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24124     Document Type: Article

References (16)

1. Kaspers GJL, Zwaan CM. Paediatric acute myeloid leukaemia: Toward high quality cure of all patients. Haematologica 2007; 92: 1519- 1532.
2. Kaspers GJL, Creutzig U. Pediatric acute myeloid leukemia: International progress and future directions. Leukemia 2005; 19: 2025- 2029.
3. Müller E, Sauter C. Routine bone marrow punctures during remission of acute myelogenous leukaemia. Leukemia 1992; 6: 419.
4. Estey E, Pierce S. Routine bone marrow exam during first remission of acute myeloid leukaemia. Blood 1996; 87: 3899- 3902.
5. Haworth C, Heppleston AD, Morris Jones PH, et al. Routine bone marrow examination in the management of acute lymphoblastic leukaemia of childhood. J Clin Pathol 1981; 34: 483- 485.
6. Haumann TJ, van Wering ER, van der Does-van den Berg A, et al. Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukaemia. Pediatr Hematol Oncol 1992; 9: 41- 47.
7. Lo Coco F, Diverio D, Avvisati G, et al. Therapy of molecular relapse in acute promyelocytic leukaemia. Blood 1999; 94: 2225- 2229.
8. Lo Coco F, Breccia M, Diverio D. The importance of molecular monitoring in acute promyelocytic leukaemia. Clin Haematol 2003; 16: 503- 520.
9. Lo Coco F, Ammatuna E. Front line clinical trials and minimal residual disease monitoring in acute promyelocytic leukaemia. Curr Top Microbiol Immunol 2007; 313: 145- 156.
10. Esteve J, Escoda L, Martin G, et al. Outcome of patients with acute promyelocytic leukaemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protcols LPG96 and LPA99): Benefit of an early intervention. Leukemia 2007; 21: 446- 452.
11. Grimwade D, Jovanovic JV, Hills RK, et al. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukaemia and to direct pre-emptive arsenic trioxide therapy. J Clin Oncol 2009; 27: 3650- 3658.
12. Rubnitz JE, Hijiya N, Zhou Y, et al. Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukaemia. Pediatr Blood Cancer 2005; 44: 138- 141.
13. Kern W, Haferlach T, Schoch C, et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukaemia: Data from the Germa AML Cooperative Group (AMLCG) 1992 Trial. Blood 2003; 101: 64- 70.
14. Langebrake C, Creutzig U, Dworzak M, et al. Residual disease monitoring in childhood acute myeloid leukaemia by multiparameter flow cytometry: The MRD-AML-BFM Study Group. J Clin Oncol 2006; 24: 3686- 3692.
15. Ommen HB, Schnittger S, Jovanovic JV, et al. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukaemias. Blood 2010; 115: 198- 205.
16. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukaemia. Hematol Oncol Clin North Am 2010; 24: 35- 63.